| hoofprints 2005-05-20, 5:56 pm |
|
Vertex Reports Positive Data for Hepatitis C Drug
Vertex Pharmaceuticals Inc. on Tuesday reported interim results from an
early-stage trial that indicate its experimental oral hepatitis C virus
drug VX-950 was well tolerated and demonstrated potent antiviral
activity.
Reuters Health Information 2005
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gco80Eq
Peginterferon Plus Ribavirin May Be Helpful in Pediatric HCV Infection
In an open-label pilot study, this combination was well tolerated and
offered encouraging results; however, the treatment is not approved for
children.
Medscape Medical News 2005
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcor0Eo
--MEDSCAPE CONFERENCE COVERAGE--
40th Annual Meeting of the European Association for the Study of the
Liver
Leading authorities provide clinically focused and comprehensive
updates on topical issues in liver disease, based on selected sessions
at the EASL 2005 meeting.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0GZSL0EZ
Advances in the Management of Hepatitis B
F. Fred Poordad, MD, discusses the latest issues in HBV infection,
including new and old therapies and drug-resistance patterns, as based
on key sessions at EASL 2005.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcou0Er
Management of Hepatitis C -- Addressing the Issues Beyond the Guidelines
Heiner Wedemeyer, MD, and Michael P. Manns, MD, report on the latest
treatments for HCV infection, based on proceedings from the 2005 EASL
conference.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcov0Es
Complications of Cirrhosis: Clinical Perspectives and Implications
Helena Cortez-Pinto, MD, PhD, reviews the current state of the field
with regard to complications of cirrhosis, including varices,
ascites/SBP, and hepatic encephalopathy, as discussed during EASL 2005.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcoy0Ev
New Developments in Hepatocellular Carcinoma
What's new in identification of risk factors, early detection, and
approach to treatment and prevention for HCC? Josep M. Llovet, MD,
explores the issues, based on key sessions at EASL 2005.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcoz0Ew
Issues in Liver Transplantation
Mitchell L. Shiffman, MD, discusses ongoing research and developments
in liver transplantation and explores issues such as the management of
recurrent hepatitis C and hepatitis B, as based on select sessions at
EASL 2005.
http://mp.medscape.com/cgi-bin1/DM/...eGA0D1T0Gcow0Et
--
{ Disclaimer: Non Existent words contained within this poast
were created in response to the Paperwork Reduction Act.}
{If you have a problem with that,
take it to the Environmentalists Complaint Dept.}
A Free Thinker.
|